Skip to main content

Fact Sheet


The study seeks to:

look at the effects of human immunodeficiency virus (HIV) infection on men and women. Researchers believe that this study may help us to understand and reduce the effect that health problems have on people living with HIV, such as heart disease.


  • HIV- and HIV+ men
  • If HIV+ and taking HAART, we require proof of HAART initiation
  • Men who are 30 years of age or older


  • initial visits: 

Screening visit – an initial screening visit about 30 minutes long.  If you are eligible, you will be given an appointment for an enrollment visit.

Baseline Enrollment visit – a full visit about 2-3 hours long and includes $100 reimbursement for time and effort

  • Private interview
  • Lab testing (for HIV, viral load, and other infections like hepatitis)
  • Physical exam


  • If eligible for enrollment, you will be asked to complete one study visit annually. Each study visit lasts 2-3 hours and includes:
    • Remote or in-person interviews
    • Lab testing (for HIV, viral load, and other infections like hepatitis)
    • Physical exams and health referrals


  • No experimental drugs or invasive procedures


  • Helping researchers better understand HIV infection and AIDS including the long-term effects of HIV medicines
  • Confidentiality/privacy; study participants receive study identification numbers
  • Free physical examinations and health assessments
  • Free laboratory testing – HIV, viral load, and other infections
  • Free health referrals
  • Flexible scheduling, including evenings and weekends in Baltimore or DC
  • A friendly, supportive environment with light refreshments
  • $100 compensation per visit for time and effort

To volunteer or for more information, please contact the SHARE study at 410-955-7090 or 1-866-392-8991 or 202-745-6137.  

Principal Investigator: Joseph Margolick, MD, PhD and Todd Brown, MD, PhD, Johns Hopkins Bloomberg School of Public Health